953040-63-6 Usage
Uses
Used in Pharmaceutical Industry:
2-Chloro-6-bromo-7-methoxyquinazoline is used as a building block for the synthesis of biologically active compounds due to its unique chemical structure and potential biological activities.
Used in Antitumor Applications:
In the field of medicinal chemistry, 2-Chloro-6-bromo-7-methoxyquinazoline is used as a potential antitumor agent, as it has been studied for its ability to exhibit antitumor activities.
Used in Antiviral Applications:
2-Chloro-6-broMo-7-Methoxyquinazoline is also used as a potential antiviral agent, as it has been investigated for its potential to combat viral infections.
Used in Antibacterial Applications:
2-Chloro-6-bromo-7-methoxyquinazoline is utilized in the development of new antibacterial drugs, given its potential to exhibit antibacterial properties.
Used in Drug Development:
In the pharmaceutical industry, 2-Chloro-6-bromo-7-methoxyquinazoline is used in the development of new drugs and pharmaceuticals, leveraging its potential biological activities and chemical properties for therapeutic purposes.
Check Digit Verification of cas no
The CAS Registry Mumber 953040-63-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,3,0,4 and 0 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 953040-63:
(8*9)+(7*5)+(6*3)+(5*0)+(4*4)+(3*0)+(2*6)+(1*3)=156
156 % 10 = 6
So 953040-63-6 is a valid CAS Registry Number.
953040-63-6Relevant academic research and scientific papers
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
-
Paragraph 0476; 0485; 0486, (2015/05/05)
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
-
Page/Page column 72; 74, (2014/02/15)
Described herein are inhibitors of FGFR, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions to inhibit the activity of tyrosine kinases.
